Altman Peter's Form 4 filing
BioCardia, Inc. (BCDA) · filed Dec 17, 2025
- Accession no.
- 0001437749-25-038200
- Filed
- Dec 17, 2025
- Trade date
- Dec 16-17, 2025
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $1.44K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Altman PeterCIK 0001647542 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 16, 2025 | Common Stock | PPurchaseAcquired | +200 | $1.37 | +$274 | 267,066 | Direct | |
| Dec 17, 2025 | Common Stock | PPurchaseAcquired | +900 | $1.30 | +$1,170 | 267,966 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.